Skip to content

Effects of corticospinal tract integrity on upper limb motor function in stroke patients treated with repetitive transcranial magnetic stimulation

Effects of corticospinal tract integrity on upper limb motor function in stroke patients treated with repetitive transcranial magnetic stimulation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100043590
Enrollment
Unknown
Registered
2021-02-23
Start date
2021-03-01
Completion date
Unknown
Last updated
2021-06-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

6:r-TMS

Sponsors

Department of Rehabilitation, Affiliated Hospital of Qingdao University, Shinan District, Qingdao City, Shandong Province
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. The patient or his immediate family members understand and sign the informed consent; 2. It conforms to the diagnosis points of "stroke" in "Diagnosis Points of Various Cerebrovascular Diseases" passed by the 4th National Academic Conference on Cerebrovascular Diseases in 1995, and is verified by cranial MRI or CT examination; 3. the presence of upper limb motor dysfunction; 4. First unilateral cerebral hemispheric stroke; Cerebral hemorrhage patients did not undergo cranial surgery; 5. Time of onset longer than 2 weeks, and less than 6 months; 6. Aged 18 to 80 years old; 7. Stable condition, conscious, vital signs stable.

Exclusion criteria

Exclusion criteria: 1. Patients with previous Parkinson's disease, peripheral neuropathy and other motor dysfunction; 2. Patients with severe cognitive, speech, visual, hearing or mental disorders that affect the examination and treatment; 3. Patients with a previous history of epilepsy or a family history of epilepsy, metal pacemakers in the body, metal implants in the brain, cochlear implants, or skull defects are not suitable for TMS therapy; 4. participating in other clinical trials that may affect the evaluation of the results of this study; 5. Those who are expected to be unable to complete the test and may have poor compliance.

Design outcomes

Primary

MeasureTime frame
Fugl-Meyer Assessment-Upper Extremity, FMA-UE;

Secondary

MeasureTime frame
Wolf motor function test, WMFT;root mean square of surface electromy ography (RMS-SEMG);

Countries

China

Contacts

Public ContactZhu Qixiu

Department of Rehabilitation, Affiliated Hospital of Qingdao University

szjzqxsx@163.com+86 13791998169

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026